Notably, SAB treatment suppressed H2O2-induced NPC apoptosis, promoted Bcl-2 expression, and inhibited the expression of Bax, thus rescuing the Bcl-2/Bax protein ratio in the SAB+H2O2 group. The gene discussed is BCL2; the disease is nasopharyngeal carcinoma.